Patents by Inventor Benjamin Kellman

Benjamin Kellman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic
    Patent number: 12636353
    Abstract: Methods and compositions for diagnosing, preventing or treating a viral infection in a subject comprising administering to a subject in need thereof an effective amount of a glycosidase or a sulfatase to degrade a glycan, such as heparan sulfate, to inhibit viral infection, such as COVID-19. Methods for identifying a glycosidase, a sulfatase, or a microbe associated with increased susceptibility to viral infection in a subject.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: May 26, 2026
    Assignee: The Regents of the University of California
    Inventors: Cameron Martino, Benjamin Kellman, Nathan Lewis, Robin Knight, Jeffrey D. Esko, Daniel Sandoval, Thomas Mandel Clausen
  • GLYCOENGINEERED ANTIBODIES
    Publication number: 20250313646
    Abstract: Disclosed herein are engineered antibodies.
    Type: Application
    Filed: April 18, 2023
    Publication date: October 9, 2025
    Inventor: Benjamin KELLMAN
  • GLYCOSYLATION ENGINEERING
    Publication number: 20250273287
    Abstract: Disclosed herein are methods and systems for engineering glycosylation. The methods and systems may use structure of sequence information of biomolecules to predict glycosylation features. The methods and systems may employ one or more trained algorithms described herein.
    Type: Application
    Filed: April 18, 2023
    Publication date: August 28, 2025
    Inventors: Nathan Lewis, Benjamin Kellman, Daniel Sandoval, Daniela Nachmanson, Wan-tien Chiang
  • APPLICATION OF MICROBIAL GLYCOSIDASE AS AN ANTI-VIRAL THERAPEUTIC, PROGNOSTIC, AND DIAGNOSTIC
    Publication number: 20230277634
    Abstract: Methods and compositions for diagnosing, preventing or treating a viral infection in a subject comprising administering to a subject in need thereof an effective amount of a glycosidase or a sulfatase to degrade a glycan, such as heparan sulfate, to inhibit viral infection, such as COVID-19. Methods for identifying a glycosidase, a sulfatase, or a microbe associated with increased susceptibility to viral infection in a subject.
    Type: Application
    Filed: August 16, 2021
    Publication date: September 7, 2023
    Inventors: Cameron Martino, Benjamin Kellman, Nathan Lewis, Robin Knight, Jeffrey D. Esko, Daniel Sandoval, Thomas Mandel Clausen